基本信息
浏览量:3
职业迁徙
个人简介
Dr. Wagner’s research focuses on real-time methods for detecting and characterizing disease outbreaks, including the development and testing of operational biosurveillance systems. In his role as director of the RODS Laboratory, Dr. Wagner led the development and implementation of two widely used biosurveillance systems: the RODS system and the National Retail Data Monitor (NRDM).
Biosurveillance is a systematic process that detects and characterizes disease outbreaks. The process involves data collection, analysis, and decision making. The purpose of biosurveillance is to determine whether an outbreak exists, and if so, to identify the biological agent, source, route of transmission, geographic extent, and other characteristics that influence decisions about antibiotics, vaccines, quarantine, and other responses.
At present, Dr. Wagner is developing a third system called BioEcon. BioEcon is a decision analytic tool for use by analysts working in health departments. BioEcon is a logical extension of Dr. Wagner’s research in biosurveillance. BioEcon addresses the problem of what is the optimal action to take in response to incoming biosurveillance data.
The success of Dr. Wagner’s research into methods to collect and analyze biosurveillance data have now produced a situation in which health departments have an abundance of biosurveillance data and face decisions about how to react to anomalies in those data.
Biosurveillance is a systematic process that detects and characterizes disease outbreaks. The process involves data collection, analysis, and decision making. The purpose of biosurveillance is to determine whether an outbreak exists, and if so, to identify the biological agent, source, route of transmission, geographic extent, and other characteristics that influence decisions about antibiotics, vaccines, quarantine, and other responses.
At present, Dr. Wagner is developing a third system called BioEcon. BioEcon is a decision analytic tool for use by analysts working in health departments. BioEcon is a logical extension of Dr. Wagner’s research in biosurveillance. BioEcon addresses the problem of what is the optimal action to take in response to incoming biosurveillance data.
The success of Dr. Wagner’s research into methods to collect and analyze biosurveillance data have now produced a situation in which health departments have an abundance of biosurveillance data and face decisions about how to react to anomalies in those data.
研究兴趣
论文共 159 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of biomedical informaticspp.104647-104647, (2024)
Journal of Biomedical Informaticsno. C (2024)
Michael M. Wagner,William R. Hogan,John Levander, Adam Darr, Matt Diller, Max Sibilla,Alexander T. Loiacono, Terence Sperringer Jr.,Shawn T. Brown
CoRR (2023)
Christopher L Moore, Jing Wang, Anthony J Battisti,Alvin Chen,Jonathan Fincke, Anita Wang,Michael Wagner,Balasundar Raju,Cristiana Baloescu
Blake Saul, Elise Ketelaar, Amjad Yaish,Michael Wagner, Robert Comrie,Grace D Brannan,Carolina Restini, Michelle Balancio
Spartan medical research journalno. 2 (2022): 36719-36719
加载更多
作者统计
#Papers: 160
#Citation: 6103
H-Index: 41
G-Index: 73
Sociability: 6
Diversity: 1
Activity: 0
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn